InflaRx (IFRX) Inventory Average (2023 - 2025)
InflaRx (IFRX) posted Inventory Average of $5.8 million for Q3 2025, down 10.22% sequentially from $6.5 million in Q2 2025, and down 44.77% YoY from $10.5 million in Q3 2024.
InflaRx (IFRX) Inventory Average (2023 - 2025) Analysis & Trends
InflaRx has reported Inventory Average for 3 years, with the latest figure at $5.8 million in Q3 2025.
- Quarterly Inventory Average fell 44.77% year-over-year to $5.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.8 million (down 44.77% YoY) and the FY2024 annual result came in at $9.9 million, changed N/A from the prior year.
- Inventory Average declined to $5.8 million in Q3 2025 per IFRX's latest filing, from $6.5 million in the prior quarter.
- Over five years, Inventory Average peaked at $12.1 million in Q1 2024 and troughed at $1.2 million in Q3 2023.
- A 3-year average of $7.9 million and a median of $7.3 million in 2025 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2025: Inventory Average surged 772.05% in 2024, then tumbled 44.77% in 2025.
- Over 3 years, Inventory Average stood at $7.0 million in 2023, then grew by 28.74% to $9.0 million in 2024, then plunged by 35.54% to $5.8 million in 2025.
- According to Business Quant data, Inventory Average over the past three periods registered $5.8 million, $6.5 million, and $7.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | InflaRx | 137.60 Mn | -46.65 Mn | 2.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.82 Mn |
| Jun 30, 2025 | 6.48 Mn |
| Mar 31, 2025 | 7.31 Mn |
| Dec 31, 2024 | 9.02 Mn |
| Sep 30, 2024 | 10.53 Mn |
| Jun 30, 2024 | 11.19 Mn |
| Mar 31, 2024 | 12.12 Mn |
| Dec 31, 2023 | 7.01 Mn |
| Sep 30, 2023 | 1.21 Mn |